The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma
Oncology · 2024 · 102 (8) · 710-719
DOI: 10.1159/000536060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 17.01.2024. Verfasst von Shun Iwai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kanazawa Medical University, Uchinada-machi, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Sodium-Glucose Transporter 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Purpose
We aimed to elucidate the functions and clinical relevance of sodium-glucose cotransporter 2 (SGLT2) in resected lung adenocarcinoma.
Methods
The protein expression of SGLT2 in tumor samples from 199 patients with lung adenocarcinoma was analyzed by immunohistochemistry, and the protein expression, clinical variables, and survival outcomes were compared.
Results
The median SGLT2 expression was significantly higher in advanced-stage and more aggressive adenocarcinomas. Age ≥70 (p < 0.01), BI ≥600 (p < 0.01), PRDX4 <25 (p < 0.01), and SGLT2 ≥12% (p = 0.03) were significant factors for RFS in multivariate analysis. Significant differences were observed in the RFS rates of the groups divided using the cutoff value of SGLT2 ≥12% (5-year RFS: 72.6% vs. 90%) (p < 0.01).
Conclusion
The expression of SGLT2 was more frequently detected in advanced-stage and more aggressive adenocarcinomas with aggressive biological behavior than in their counterparts. The survival analysis revealed that the strong expression of SGLT2 was associated with poorer RFS. The SGLT2 expression predicts postoperative recurrence in lung adenocarcinoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Kanazawa Medical University, Uchinada-machi, Japan.
- Imamitsu Home Care Clinic, Kitakyushu, Japan.
- Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada-machi, Japan.
Zitieren
APA
Iwai, S., Motono, N., Oyama, T., Shioya, A., Yamada, S., & Uramoto, H. (2024). The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma. Oncology, 102(8), 710-719. https://doi.org/10.1159/000536060
Vancouver
Iwai S, Motono N, Oyama T, Shioya A, Yamada S, Uramoto H. The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma. Oncology. 2024;102(8):710-719. doi:10.1159/000536060
BibTeX
@article{Iwai2024,
author = {Iwai, Shun and Motono, Nozomu and Oyama, Tsunehiro and Shioya, Akihiro and Yamada, Sohsuke and Uramoto, Hidetaka},
title = {The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma},
journal = {Oncology},
year = {2024},
volume = {102},
number = {8},
pages = {710--719},
doi = {10.1159/000536060}
}
EUVIMED